Lantern Pharma Inc.LTRNNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+63.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+63.2%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
4.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$751710.00-47.6%
2024$1.44M-25.1%
2023$1.92M+1008.8%
2022$172807.00-24.4%
2021$228479.00-
2020$0.00-
2019$0.00-
2018$0.00-